wmedicinereport.com
Home » Medications »
South San Francisco, CA — June 25, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older. […]
Read more
Stopping long-term opioid treatment does not make chronic, non-cancer-related pain worse and, in some cases, makes it better, Washington State University researchers have found. The research marks a crucial first step towards understanding how ending long-term opioid therapy affects patients with different types of chronic pain and could help medical practitioners identify effective, alternative treatments to opioids. “On average, pain […]
Read more
(HealthDay)—New laws and regulations designed to limit the use of prescription narcotics may further constrain doctors’ ability to treat patients, according to an article published online May 30 in Medical Economics. Physicians and public health and pain management experts are concerned that laws and regulations may represent another constraint on doctors’ ability to treat patients in the way they think […]
Read more
(HealthDay)—The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome for patients age 2 years and older. The rare, genetic Dravet syndrome appears during the first year of life with frequent fever-related seizures; other types of seizures arise later, and status epilepticus may occur. Lennox-Gastaut syndrome begins […]
Read more